首页> 外文期刊>Clinical cardiology. >A retrospective review to evaluate the safety of right heart catheterization via the internal jugular vein in the assessment of pulmonary hypertension.
【24h】

A retrospective review to evaluate the safety of right heart catheterization via the internal jugular vein in the assessment of pulmonary hypertension.

机译:回顾性评估通过右颈内静脉置管右心导管在评估肺动脉高压中的安全性。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Right heart catheterization (RHC) is important in the evaluation of pulmonary hypertension, but is not without risk. HYPOTHESIS: We wished to assess the safety, efficacy, and tolerability of RHC performed via the internal jugular vein (IJV) at our tertiary cardiothoracic center. METHODS: A retrospective review of the medical records for all patients undergoing RHC via the IJV between January 1, 2007 and July 31, 2009 was performed. We do not routinely use ultrasound guidance or stop anticoagulation. Operators with a median experience of 450 procedures performed the RHCs. RESULTS: Right heart catheterization was performed on 349 patients with a median age of 66 years (range, 17-89), median mean pulmonary artery pressure of 30 mm Hg (range, 8-69), and a median internationalized normal ratio of 2.5. Of 349 patients, we were unable to obtain intravenous access in only 1 patient; 342 (98%) patients tolerated RHC with local anesthetic alone; and 6 patients required additional sedation with benzodiazepines. The median time for the procedure was 15 minutes. Complications occurred in 6 patients (1.7%) and included carotid puncture (n = 3), sinus bradycardia below 45 beats/min, which responded promptly to atropine and intravenous fluid (n = 2), and complete heart block without hemodynamic compromise (n = 1). There were no pneumothoraxes, pulmonary hemorrhage, or deaths related to the procedure. CONCLUSION: Right heart catheterization via the IJV is quick, safe, and well tolerated. It is not associated with an increased risk of pneumothorax or other complications when performed by experienced operators.
机译:背景:右心导管检查(RHC)在评估肺动脉高压中很重要,但并非没有风险。假设:我们希望评估在我们的第三心胸中心通过颈内静脉(IJV)进行的RHC的安全性,疗效和耐受性。方法:对2007年1月1日至2009年7月31日期间通过IJV接受RHC的所有患者的病历进行回顾性回顾。我们不会常规使用超声引导或停止抗凝。具有450次手术中位经验的操作员进行了RHC。结果:349例患者进行了右心导管检查,中位年龄为66岁(范围17-89),平均肺动脉压中位数为30 mm Hg(范围8-69),中位国际化正常比率为2.5 。在349例患者中,只有1例患者无法获得静脉注射。 342名(98%)患者仅使用局麻药就可以耐受RHC; 6例患者需要使用苯二氮卓类药物进行其他镇静。该过程的中位时间为15分钟。 6例患者发生并发症(1.7%),包括颈动脉穿刺(n = 3),窦性心动过缓低于45次/分钟,对阿托品和静脉输液迅速反应(n = 2),完全性心脏传导阻滞而无血流动力学损害(n = 1)。没有气胸,肺出血或与手术相关的死亡。结论:通过IJV进行右心导管插入术快速,安全且耐受性良好。由经验丰富的操作员进行操作时,它不会增加气胸或其他并发症的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号